جلد 11، شماره 4 - ( 8-1401 )
جلد 11 شماره 4 صفحات 35-30 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ebrahimi Fakhari M, Ghaznavi A, Bayani M, Anvari M. Research Paper: Evaluation of Visfatin levels in
Gingival Crevicular Fluid in Association between Coronary Heart Disease and Chronic Periodontitis. Journal title 2022; 11 (4) :30-35
URL: http://3dj.gums.ac.ir/article-1-563-fa.html
URL: http://3dj.gums.ac.ir/article-1-563-fa.html
Research Paper: Evaluation of Visfatin levels in
Gingival Crevicular Fluid in Association between Coronary Heart Disease and Chronic Periodontitis. عنوان نشریه. 1401; 11 (4) :30-35
چکیده: (576 مشاهده)
Abstract
Introduction: The aim of this study is to evaluate the Visfatin levels in Gingival Crevicular Fluid in Association between Coronary Heart Disease and Chronic Periodontitis.
Materials and Methods: This matched case control study was conducted on 60 CHD patients and 60 controls. These participants were divided to four groups as follow: 1) patients with both CHD and CP (n=30), 2) patients with CHD and
without CP (n=30), 3) patients with CP and without CHD (n=30), and 4) healthy subjects (n=30). The amount of visfatin in GCF samples of these participants were evaluated by
Enzyme Linked Immunosorbent Assay (ELISA).
Results: The amount of visfatin in GCF of CHD patients with CP and CP patients were significantly higher than healthy subjects (P<0.001).
Conclusion: Visfatin levels in GCF of CHD patients with CP and CP patients can help to better understand the probable inflammatory process of the CHD and CP
Introduction: The aim of this study is to evaluate the Visfatin levels in Gingival Crevicular Fluid in Association between Coronary Heart Disease and Chronic Periodontitis.
Materials and Methods: This matched case control study was conducted on 60 CHD patients and 60 controls. These participants were divided to four groups as follow: 1) patients with both CHD and CP (n=30), 2) patients with CHD and
without CP (n=30), 3) patients with CP and without CHD (n=30), and 4) healthy subjects (n=30). The amount of visfatin in GCF samples of these participants were evaluated by
Enzyme Linked Immunosorbent Assay (ELISA).
Results: The amount of visfatin in GCF of CHD patients with CP and CP patients were significantly higher than healthy subjects (P<0.001).
Conclusion: Visfatin levels in GCF of CHD patients with CP and CP patients can help to better understand the probable inflammatory process of the CHD and CP
| بازنشر اطلاعات | |
 | این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
